Persistent Suicide Risk in Survivors of Testicular Cancer: A Population-Based Cohort Study

Men with testicular cancer had 31% higher suicide mortality than the general population; risk doubled in year one and persisted for 10 years

Journal: Urologic Oncology | Published: 2026-04-15 | Type: Cohort Study | PMID: 41991382 Authors: Wen et al., Department of Urology, Loma Linda University Health (all authors from same institution) Funding/COI: Funding not listed. Authors declare no competing financial interests.

Summary

Testicular cancer has roughly a 95% five-year survival rate — yet surviving it doesn't eliminate mortality risk from psychological causes. This SEER database analysis of 46,395 patients found that testicular cancer patients die by suicide at a rate 31% higher than age- and gender-matched peers, with the risk spiking to 2.21x in the first year post-diagnosis. The elevated risk doesn't resolve with time: it remained statistically significant even 5–10 years after diagnosis.

Claims

• 125 of 46,395 patients (0.27%) died by suicide over the 2000–2021 study period
• Overall SMR for suicide: 1.31 (95% CI: 1.29–1.35) vs. age-adjusted, gender-matched US general population
• SMR by time from diagnosis: 2.21 (95% CI: 2.10–2.32) in year 1; 1.24 (95% CI: 1.19–1.29) at 1–5 years; 1.08 (95% CI: 1.03–1.14) at 5–10 years
• SMR by disease stage: localized 1.07, regional 1.48, distant 2.29
• Variables associated with higher suicide risk: separated, divorced, or widowed relationship status; race (specific breakdown not provided in abstract)

Study Quality

SEER is the appropriate database for this question — large, population-based, nationally representative, with 22 years of follow-up. Standardized mortality ratios with age- and gender-matching is a clean approach for comparing against background population rates. Stratifying by both stage and time from diagnosis adds meaningful granularity. With 46,395 patients, the study has sufficient power to detect even modest elevation in a rare outcome.

The core limitation is structural and unavoidable: SEER records cause of death, not psychiatric history, mental health treatment, income, insurance status, or social support network — all of which are likely mediators between cancer diagnosis and suicide risk. The "race" and "relationship status" findings are therefore proxies for structural factors, not causal mechanisms.

Red Flags

• 125 total suicide deaths is a small absolute number; the SMR signal is real but rare in absolute terms
• No detail on multivariate adjustment — the race and relationship status associations could reflect confounding
• All authors at a single institution (Loma Linda), though this shouldn't affect SEER analysis validity
• No funding source listed; unclear if this was grant-supported or unfunded
• Abstract doesn't specify which racial groups carried elevated risk or how large the effect was

Strengths

• Large, nationally representative sample (n = 46,395)
• 22-year study window (2000–2021) with meaningful follow-up time
• Proper age- and gender-matching for SMR calculation
• Stage-stratified and time-stratified analyses add clinical specificity
• No declared conflicts of interest
• Population-based design avoids referral center selection bias

Verdict

Methodologically sound for what SEER can answer. The 2.21x first-year SMR is the number that matters: testicular cancer patients are dying by suicide at double the background rate in the first year after diagnosis, in a cancer where the disease itself is rarely fatal. The finding that risk persists — statistically significant — five to ten years later is the more novel contribution. What this paper cannot do is explain the mechanism or test any intervention, and the conclusion's call for "psychosocial screening" exceeds what the data actually demonstrate. Still, the signal is clear and the study is appropriately scoped.